[A 2022 inventory in oncology news].
Que retenir dans la prise en charge des cancers en 2022 ?
Actualités 2022 en cancérologie
New treatments in oncology
Nouveaux traitements
Updates in 2022
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
01
12
2022
accepted:
05
12
2022
pubmed:
19
12
2022
medline:
14
1
2023
entrez:
18
12
2022
Statut:
ppublish
Résumé
The Cancer Bulletin continues its tradition. At the beginning of 2023, the members of the editorial committee would like to share with you their analyses of the highlights of 2022. The objective remains to highlight what will change our practices and lead to different diagnostic or therapeutic options. Our synthesis will therefore focus on published data. They have been analyzed and placed in the more general context of the management of each type of cancer to deduce the practical consequences for our patients. This synthesis exercise will concern almost all tumor pathologies, most often on the therapeutic level, and will, however, exclude the evolution of techniques, whether they are diagnostic or used for the follow-up of our patients. The final objective is to allow you to have a thoughtful, didactic and practical reading. Our goal is to provide our readers with the rational bases that can lead to a different approach for treatments in 2023.
Identifiants
pubmed: 36529541
pii: S0007-4551(22)00437-4
doi: 10.1016/j.bulcan.2022.12.002
pii:
doi:
Types de publication
English Abstract
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
19-31Informations de copyright
Copyright © 2022. Published by Elsevier Masson SAS.